Schroder Investment Management Group raised its position in Hutchison China MediTech Ltd – (NASDAQ:HCM) by 26.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 416,537 shares of the company’s stock after buying an additional 87,485 shares during the period. Schroder Investment Management Group owned about 0.74% of Hutchison China MediTech Ltd – worth $5,477,000 at the end of the most recent reporting period.

Separately, SG Americas Securities LLC boosted its position in shares of Hutchison China MediTech Ltd – by 78.7% in the second quarter. SG Americas Securities LLC now owns 31,010 shares of the company’s stock worth $408,000 after buying an additional 13,653 shares during the last quarter.

Shares of Hutchison China MediTech Ltd – (NASDAQ:HCM) traded down 1.44% on Monday, hitting $12.29. The company’s stock had a trading volume of 57,642 shares. The firm’s market cap is $1.49 billion. Hutchison China MediTech Ltd – has a 52 week low of $9.80 and a 52 week high of $14.70. The stock’s 50-day moving average price is $12.80 and its 200-day moving average price is $13.13.

A number of brokerages have issued reports on HCM. Zacks Investment Research raised Hutchison China MediTech Ltd – from a “hold” rating to a “buy” rating and set a $15.00 price objective for the company in a report on Tuesday, June 21st. Canaccord Genuity reissued a “buy” rating on shares of Hutchison China MediTech Ltd – in a report on Tuesday, August 2nd. Beaufort Securities reissued a “buy” rating on shares of Hutchison China MediTech Ltd – in a report on Wednesday, August 3rd. Finally, Stifel Nicolaus set a $20.00 price objective on Hutchison China MediTech Ltd – and gave the company a “buy” rating in a report on Monday, August 1st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $18.33.

About Hutchison China MediTech Ltd –

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.

5 Day Chart for NASDAQ:HCM

Want to see what other hedge funds are holding HCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hutchison China MediTech Ltd – (NASDAQ:HCM).

Receive News & Ratings for Hutchison China MediTech Ltd - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech Ltd - and related companies with Analyst Ratings Network's FREE daily email newsletter.